Stay updated on HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Sign up to get notified when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.

Latest updates to the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated from version 2.15.1 to version 2.15.2.SummaryDifference0.3%
- Check10 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.1.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the way information is presented.SummaryDifference1.0%
- Check25 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 17, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference1.0%
- Check32 days agoNo Change Detected
- Check69 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting NLM-NCBI services and products, as well as a specific date. Additionally, a new date has been added.SummaryDifference6%
- Check84 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference6%
Stay in the know with updates to HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.